HomeDSGN • NASDAQ
Design Therapeutics Inc
add
$4.71
0.32%
After Hours:(0.00%)0.00
$4.71
Closed: Mar 14, 4:10:01 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.54M | 10.42% |
Net income | -13.65M | -15.28% |
Net profit margin | — | — |
Earnings per share | -0.24 | -14.29% |
EBITDA | -16.55M | -10.43% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 245.48M | -12.89% |
Total assets | 252.09M | -12.96% |
Total liabilities | 10.00M | -16.39% |
Total equity | 242.10M | — |
Shares outstanding | 56.76M | — |
Price to book | 1.11 | — |
Return on assets | -16.25% | — |
Return on capital | -16.71% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -13.65M | -15.28% |
Cash from operations | -9.86M | 22.96% |
Cash from investing | 1.83M | -67.02% |
Cash from financing | 263.00K | -47.50% |
Net change in cash | -7.77M | -15.17% |
Free cash flow | -5.20M | 39.42% |
Previous close
$4.72
Day range
$4.70 - $4.95
Year range
$2.45 - $7.77
Market cap
266.40M USD
Avg Volume
166.38K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2017
Headquarters
Website
Employees
54
